Abbott Laboratories Shares Outstanding 2006-2018 | ABT

Abbott Laboratories shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Abbott Laboratories shares outstanding for the quarter ending September 30, 2018 were 1.772B, a 1% increase year-over-year.
  • Abbott Laboratories 2017 shares outstanding were 1.749B, a 17.94% increase from 2016.
  • Abbott Laboratories 2016 shares outstanding were 1.483B, a 1.53% decline from 2015.
  • Abbott Laboratories 2015 shares outstanding were 1.506B, a 1.38% decline from 2014.
Abbott Laboratories Annual Shares Outstanding
(Millions of Shares)
2017 1,749
2016 1,483
2015 1,506
2014 1,527
2013 1,574
2012 1,592
2011 1,567
2010 1,556
2009 1,555
2008 1,561
2007 1,560
2006 1,537
2005 1,564
Abbott Laboratories Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 1,772
Q2 2018 1,769
Q1 2018 1,765
Q4 2017 1,749
Q3 2017 1,754
Q2 2017 1,749
Q1 2017 1,735
Q4 2016 1,483
Q3 2016 1,476
Q2 2016 1,480
Q1 2016 1,484
Q4 2015 1,506
Q3 2015 1,505
Q2 2015 1,504
Q1 2015 1,516
Q4 2014 1,527
Q3 2014 1,520
Q2 2014 1,517
Q1 2014 1,548
Q4 2013 1,574
Q3 2013 1,567
Q2 2013 1,577
Q1 2013 1,586
Q4 2012 1,592
Q3 2012 1,594
Q2 2012 1,589
Q1 2012 1,590
Q4 2011 1,577
Q3 2011 1,568
Q2 2011 1,566
Q1 2011 1,559
Q4 2010 1,556
Q3 2010 1,554
Q2 2010 1,552
Q1 2010 1,561
Q4 2009 1,555
Q3 2009 1,552
Q2 2009 1,551
Q1 2009 1,556
Q4 2008 1,561
Q3 2008 1,564
Q2 2008 1,553
Q1 2008 1,561
Q4 2007 1,560
Q3 2007 1,558
Q2 2007 1,561
Q1 2007 1,558
Q4 2006 1,537
Q3 2006 1,542
Q2 2006 1,532
Q1 2006 1,538
Q4 2005 1,564
Q3 2005 1,564
Q2 2005 1,569
Q1 2005 1,570
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $126.175B $27.390B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $128.221B 19.17
Stryker (SYK) United States $64.233B 24.21
Boston Scientific (BSX) United States $50.592B 25.57
Baxter (BAX) United States $35.222B 22.75
Zimmer Biomet Holdings (ZBH) United States $22.847B 14.82
Smith & Nephew SNATS (SNN) United Kingdom $16.598B 0.00
ResMed (RMD) United States $16.236B 30.96
Perrigo (PRGO) Ireland $7.946B 12.06
Canopy Growth (CGC) Canada $7.699B 0.00
Bio-Rad Laboratories (BIO) United States $7.552B 48.29
Hill-Rom Holdings (HRC) United States $6.323B 19.78
Aurora Cannabis (ACB) Canada $5.910B 31.21
Haemonetics (HAE) United States $5.336B 46.93
Insulet (PODD) United States $4.873B 0.00
ICU Medical (ICUI) United States $4.821B 26.86
Hutchison China MediTech (HCM) China $4.050B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.710B 0.00
Neogen (NEOG) United States $3.247B 49.17
Agios Pharmaceuticals (AGIO) United States $3.172B 0.00
NuVasive (NUVA) United States $2.911B 27.09
National Vision Holdings (EYE) United States $2.497B 48.30
Quidel (QDEL) United States $2.014B 26.26
NxStage Medical (NXTM) United States $1.931B 0.00
Aphria (APHA) $1.534B 0.00
Phibro Animal Health (PAHC) United States $1.321B 18.70
AtriCure (ATRC) United States $1.182B 0.00
Cardiovascular Systems (CSII) United States $1.013B 1457.00
VAREX IMAGING (VREX) United States $0.925B 18.53
PetIQ (PETQ) United States $0.844B 21.86
Surmodics (SRDX) United States $0.784B 119.47
Meridian Bioscience (VIVO) United States $0.783B 24.96
Cerus (CERS) United States $0.753B 0.00
OraSure Technologies (OSUR) United States $0.733B 41.24
Omeros (OMER) United States $0.709B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.658B 21.10
Lantheus Holdings (LNTH) United States $0.652B 20.18
MacroGenics (MGNX) United States $0.600B 0.00
NanoString Technologies (NSTG) United States $0.534B 0.00
LeMaitre Vascular (LMAT) United States $0.512B 25.14
Owens & Minor (OMI) United States $0.443B 5.01
Quanterix (QTRX) United States $0.429B 0.00
TG Therapeutics (TGTX) United States $0.418B 0.00
Insys Therapeutics (INSY) United States $0.376B 0.00
Evolus (EOLS) United States $0.355B 0.00
Utah Medical Products (UTMD) United States $0.329B 21.25
VAPOTHERM INC (VAPO) United States $0.317B 0.00
Cytosorbents (CTSO) United States $0.278B 0.00
Bovie Medical (BVX) United States $0.240B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.240B 0.00
Surface Oncology (SURF) United States $0.238B 0.00
BioLife Solutions (BLFS) United States $0.213B 288.50
Chimerix (CMRX) United States $0.174B 0.00
Rockwell Medical (RMTI) United States $0.173B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.139B 0.00
Fonar (FONR) United States $0.132B 6.65
Chembio Diagnostics (CEMI) United States $0.107B 0.00
United-Guardian (UG) United States $0.079B 16.60
Female Health (VERU) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
InfuSystems Holdings (INFU) United States $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.064B 17.87
CAS Medical Systems (CASM) United States $0.055B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Neurotrope (NTRP) United States $0.039B 0.00
Myomo (MYO) United States $0.021B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
Senestech (SNES) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00